Recovery of avirulent, thermostable Newcastle disease virus strain NDV4-C from cloned cDNA and stable expression of an inserted foreign gene

Archives of Virology

Volumn 158, Issue 10, 2013, Pages 2115-2120

  Zhang, Xintao ^a   Liu, Huairan ^a   Liu, Peixin ^a   Peeters, Ben P H ^b   Zhao, Chenchen ^a   Kong, Xiangang ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA DIRECTED RNA POLYMERASE; VIRUS DNA;

ARTICLE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR CLONING; NEWCASTLE DISEASE PARAMYXOVIRUS; PATHOGENICITY; VIRULENCE;

CLONING, MOLECULAR; DNA, COMPLEMENTARY; DNA, VIRAL; DNA-DIRECTED RNA POLYMERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, VIRAL; NEWCASTLE DISEASE VIRUS; VIRULENCE;

NEWCASTLE DISEASE VIRUS;

EID: 84884820849     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-013-1723-6     Document Type: Article

References (36)

1. Alexander DJ (1989) Newcastle disease. In: Purchase HG, Arp LH, Domermuth CH, Perason JE (eds) A laboratory manual for the isolation and identification of avian pathogens, 3rd edn. American Association of Avian Pathologists, Kennett Square, PA, pp 114-120.
2. Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73: 251-259.
3. Czegledi A, Ujvari D, Somogyi E, Wehmann E, Werner O, Lomniczi B (2006) Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res 120: 36-48.
4. DiNapoli JM, Yang LJ, Samal SK, Murphy BR, Collins PL, Bukreyev A (2010) Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine 29: 17-25.
5. Dortmans JC, Rottier PJ, Koch G, Peeters BP (2010) The viral replication complex is associated with the virulence of Newcastle disease virus. J Virol 84: 10113-10120.
6. Hu H, Roth JP, Estevez CN, Zsak L, Liu B, Yu Q (2011) Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys. Vaccine 29: 8624-8633.
7. Hu S, Ma H, Wu Y, Liu W, Wang X, Liu Y, Liu X (2009) A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 27: 904-910.
8. Huang Y, Wan HQ, Liu HQ, Wu YT, Liu XF (2004) Genomic sequence of an isolate of Newcastle disease virus isolated from an outbreak in geese: a novel six nucleotide insertion in the non-coding region of the nucleoprotein gene. Brief report. Arch Virol 149: 1445-1457.
9. Huang Z, Krishnamurthy S, Panda A, Samal SK (2001) High-level expression of a foreign gene from the most 3′-proximal locus of a recombinant Newcastle disease virus. J Gen Virol 82: 1729-1736.
10. Huang Z, Panda A, Elankumaran S, Govindarajan D, Rockemann DD, Samal SK (2004) The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol 78: 4176-4184.
11. Ibrahim AL, Chulan U, Babjee AM (1981) An assessment of the Australian V4 strain of Newcastle disease virus as a vaccine by spray, aerosol and drinking water administration. Aust Vet J 57: 277-280.
12. Jiang Y, Liu H, Liu P, Kong X (2009) Plasmids driven minigenome rescue system for Newcastle disease virus V4 strain. Mol Biol Rep 36: 1909-1914.
13. Kattenbelt JA, Meers J, Gould AR (2006) Genome sequence of the thermostable Newcastle disease virus (strain I-2) reveals a possible phenotypic locus. Vet Microbiol 114: 134-141.
14. Kim SJ, Spradbrow PB (1978) Administration of a vaccine prepared from the Australian V4 strain of Newcastle disease virus by aerosol and drinking water. Aust Vet J 54: 486-489.
15. Lawson ND, Stillman EA, Whitt MA, Rose JK (1995) Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci USA 92: 4477-4481.
16. Mayo MA (2002) Virus taxonomy-Houston 2002. Arch Virol 147: 1071-1076.
17. Mazija H, Cajavec S, Ergotic N, Ciglar-Grozdanic I, Gottstein Z, Ragland WL (2010) Immunogenicity and safety of Queensland V4 and Ulster 2C strains of Newcastle disease virus given to maternally immune, newly hatched chickens by nebulization. Avian Dis 54: 99-103.
18. Mebatsion T, Verstegen S, De Vaan LT, Romer-Oberdorfer A, Schrier CC (2001) A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J Virol 75: 420-428.
19. Olabode AO, Ndako JA, Echeonwu GO, Nwankiti OO, Chukwuedo AA (2010) Use of cracked maize as a carrier for NDV4 vaccine in experimental vaccination of chickens. Virol J 7: 67.
20. Panda A, Huang Z, Elankumaran S, Rockemann DD, Samal SK (2004) Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog 36: 1-10.
21. Park MS, Steel J, Garcia-Sastre A, Swayne D, Palese P (2006) Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci USA 103: 8203-8208.
22. Peeters BP, de Leeuw OS, Koch G, Gielkens AL (1999) Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73: 5001-5009.
23. Peeters BP, Gruijthuijsen YK, de Leeuw OS, Gielkens AL (2000) Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch Virol 145: 1829-1845.
24. Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dotsch C, Christiansen G, Billeter MA (1995) Rescue of measles viruses from cloned DNA. EMBO J 14: 5773-5784.
25. Ramp K, Skiba M, Karger A, Mettenleiter TC, Romer-Oberdorfer A (2011) Influence of insertion site of the avian influenza virus haemagglutinin (HA) gene within the Newcastle disease virus genome on HA expression. J Gen Virol 92: 355-360.
26. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27: 493-497.
27. Rout SN, Samal SK (2008) The large polymerase protein is associated with the virulence of Newcastle disease virus. J Virol 82: 7828-7836.
28. Schnell MJ, Mebatsion T, Conzelmann KK (1994) Infectious rabies viruses from cloned cDNA. EMBO J 13: 4195-4203.
29. Simmons GC (1967) The isolation of Newcastle disease virus in Queensland. Aust Vet J 43: 29-30.
30. Steward M, Vipond IB, Millar NS, Emmerson PT (1993) RNA editing in Newcastle disease virus. J Gen Virol 74(Pt 12): 2539-2547.
31. Tan WS, Lau CH, Ng BK, Ibrahim AL, Yusoff K (1995) Nucleotide sequence of the haemagglutinin-neuraminidase (HN) gene of a Malaysian heat resistant viscerotropic-velogenic Newcastle disease virus (NDV) strain AF2240. DNA Seq 6: 47-50.
32. Volchkov VE, Volchkova VA, Muhlberger E, Kolesnikova LV, Weik M, Dolnik O, Klenk HD (2001) Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291: 1965-1969.
33. Xu Z, Sun L, Zhou J (1996) Breeding of variants Newcastle disease virus V4. Chin J Prev Veterinary Med 6: 20-23.
34. Yusoff K, Tan WS, Lau CH, Ng BK, Ibrahim AL (1996) Sequence of the haemagglutinin-neuraminidase gene of the Newcastle disease virus oral vaccine strain V4(UPM). Avian Pathol 25: 837-844.
35. Zhao H, Peeters BP (2003) Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication. J Gen Virol 84: 781-788.
36. Zulkifli MM, Ibrahim R, Ali AM, Aini I, Jaafar H, Hilda SS, Alitheen NB, Abdullah JM (2009) Newcastle diseases virus strain V4UPM displayed oncolytic ability against experimental human malignant glioma. Neurol Res 31: 3-10.